OPRX - OptimizeRx EPS beats by $0.05 beats on revenue August, 05 2020 04:04 PM OptimizeRx Corporation OptimizeRx (NASDAQ:OPRX): Q2 Non-GAAP EPS of $0.02 beats by $0.05; GAAP EPS of -$0.07 beats by $0.06.More news on: OptimizeRx Corporation, Earnings news and commentary, Consumer stocks news, , Read more ...